PHARMOCANN GLOBAL LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240 ILa | 0.00% |
|
0.00% | +71.31% |
| 16/04 | Pharmocann Global Ltd announced that it has received ILS 0.15554 million in funding | CI |
| 31/03 | Pharmocann Global Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical Farming
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 16.34L | - | - | - | - | - | |
| 22Cr | - | |||||
| 19Cr | - | |||||
| 16Cr | - | - | - | |||
| 12Cr | - | - | - | - | - | |
| 11Cr | - |
